These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

973 related items for PubMed ID: 24994869

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis.
    Hedayatfar A, Hashemi H, Asgari S, Chee SP.
    Cornea; 2014 Apr; 33(4):366-72. PubMed ID: 24351572
    [Abstract] [Full Text] [Related]

  • 44. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
    Ousler GW, Michaelson C, Christensen MT.
    Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC, Jeong IY, Park YG, Yang SY.
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ, Bickle KM, Zink RC, Schiewe MD, Haque RM, Nichols KK.
    Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
    Prabhasawat P, Tesavibul N, Mahawong W.
    Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Evaluation of topical cyclosporine for the treatment of dry eye disease.
    Perry HD, Solomon R, Donnenfeld ED, Perry AR, Wittpenn JR, Greenman HE, Savage HE.
    Arch Ophthalmol; 2008 Aug; 126(8):1046-50. PubMed ID: 18695097
    [Abstract] [Full Text] [Related]

  • 59. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S, Oshiden K, Awamura S, Suzuki H, Nakamichi N, Yokoi N, Rebamipide Ophthalmic Suspension Phase 3 Study Group.
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.